Verastem (VSTM) Cash from Investing Activities (QoQ) (2011 - 2026)
Verastem (VSTM) Cash from Investing Activities (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Verastem | 607.94 Mn | 410.11 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,090.71% |
| Jun 30, 2024 | -6.41% |
| Mar 31, 2024 | 149.11% |
| Dec 31, 2023 | 117.75% |
| Sep 30, 2023 | -600.56% |
| Jun 30, 2023 | 1,841.29% |
| Mar 31, 2023 | -106.17% |
| Dec 31, 2022 | 180.29% |
| Sep 30, 2022 | -84.11% |
| Jun 30, 2022 | 51.83% |
| Mar 31, 2022 | 29,087.88% |
| Dec 31, 2021 | -99.34% |
| Sep 30, 2021 | 317.89% |
| Jun 30, 2021 | 119.34% |
| Mar 31, 2021 | 84.41% |
| Dec 31, 2020 | -1,322,900.00% |
| Sep 30, 2020 | 77.78% |
| Jun 30, 2020 | -100.08% |
| Mar 31, 2020 | 27.56% |
| Dec 31, 2019 | 42.81% |